Fennec Pharmaceuticals (FENC) Debt Ratio (2010 - 2022)
Fennec Pharmaceuticals posted quarterly Debt Ratio of 0.82 for Q3 2022, up 155.91% on a QoQ basis from 0.32 in Q2 2022.
Fennec Pharmaceuticals (FENC) has 10 years of Debt Ratio data on file, last reported at 0.82 in Q3 2022.
- For the quarter ending Q3 2022, Debt Ratio changed N/A year-over-year to 0.82; the trailing twelve-month figure through Sep 2022 stood at 0.82 (changed N/A YoY), and the FY2021 full-year result was 0.22, changed N/A from the prior year.
- Debt Ratio for Q3 2022 stood at 0.82, up from 0.32 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.82 in Q3 2022 and bottomed at 0.22 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.18 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 1.41 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.05 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 0.82 |
| Jun 30, 2022 | 0.32 |
| Mar 31, 2022 | 0.26 |
| Dec 31, 2021 | 0.22 |
| Dec 31, 2017 | 5.88 |
| Sep 30, 2017 | 0.04 |
| Jun 30, 2017 | 0.02 |
| Mar 31, 2017 | 0.02 |
| Dec 31, 2016 | 0.01 |
| Sep 30, 2016 | 0.01 |
| Jun 30, 2016 | 0.01 |
| Mar 31, 2016 | 0.07 |
| Dec 31, 2015 | 0.08 |
| Sep 30, 2015 | 0.06 |
| Jun 30, 2015 | 0.17 |
| Mar 31, 2015 | 0.36 |
| Dec 31, 2014 | 0.56 |
| Sep 30, 2014 | 5.20 |
| Jun 30, 2014 | 5.09 |
| Mar 31, 2014 | 3.96 |
| Dec 31, 2013 | 1.63 |
| Sep 30, 2013 | 6.85 |
| Jun 30, 2013 | 2.60 |
| Mar 31, 2013 | 5.27 |
| Dec 31, 2012 | 2.81 |
| Sep 30, 2012 | 0.42 |
| Jun 30, 2012 | 0.31 |
| Mar 31, 2012 | 0.37 |
| Dec 31, 2011 | 0.95 |
| Sep 30, 2011 | 1.51 |
| Jun 30, 2011 | 1.06 |
| Dec 31, 2010 | 1.74 |